JP2023123520A5 - - Google Patents

Download PDF

Info

Publication number
JP2023123520A5
JP2023123520A5 JP2023093720A JP2023093720A JP2023123520A5 JP 2023123520 A5 JP2023123520 A5 JP 2023123520A5 JP 2023093720 A JP2023093720 A JP 2023093720A JP 2023093720 A JP2023093720 A JP 2023093720A JP 2023123520 A5 JP2023123520 A5 JP 2023123520A5
Authority
JP
Japan
Prior art keywords
composition
protein
seq
nucleic acid
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023093720A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023123520A (ja
Filing date
Publication date
Priority claimed from JP2019514770A external-priority patent/JP7432362B2/ja
Application filed filed Critical
Publication of JP2023123520A publication Critical patent/JP2023123520A/ja
Publication of JP2023123520A5 publication Critical patent/JP2023123520A5/ja
Pending legal-status Critical Current

Links

JP2023093720A 2016-09-16 2023-06-07 modRNAの細胞特異的発現 Pending JP2023123520A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662395701P 2016-09-16 2016-09-16
US62/395,701 2016-09-16
JP2019514770A JP7432362B2 (ja) 2016-09-16 2017-09-18 modRNAの細胞特異的発現
PCT/US2017/052035 WO2018053414A1 (en) 2016-09-16 2017-09-18 Cell-specific expression of modrna

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019514770A Division JP7432362B2 (ja) 2016-09-16 2017-09-18 modRNAの細胞特異的発現

Publications (2)

Publication Number Publication Date
JP2023123520A JP2023123520A (ja) 2023-09-05
JP2023123520A5 true JP2023123520A5 (https=) 2024-05-14

Family

ID=61619271

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019514770A Active JP7432362B2 (ja) 2016-09-16 2017-09-18 modRNAの細胞特異的発現
JP2023093720A Pending JP2023123520A (ja) 2016-09-16 2023-06-07 modRNAの細胞特異的発現

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019514770A Active JP7432362B2 (ja) 2016-09-16 2017-09-18 modRNAの細胞特異的発現

Country Status (9)

Country Link
US (3) US11299749B2 (https=)
EP (2) EP4316587A3 (https=)
JP (2) JP7432362B2 (https=)
CN (1) CN110177578B (https=)
AU (2) AU2017326535B2 (https=)
BR (1) BR112019005144A2 (https=)
CA (1) CA3036710A1 (https=)
ES (1) ES2967788T3 (https=)
WO (1) WO2018053414A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3036710A1 (en) * 2016-09-16 2018-03-22 Icahn School Of Medicine At Mount Sinai Cell-specific expression of modrna
EP3778902A4 (en) * 2018-03-30 2021-12-29 Kyoto University Cell production method
MX2022001664A (es) 2019-08-09 2022-07-19 Nutcracker Therapeutics Inc Aparato microfluídico y metodos de uso del mismo.
US12606822B2 (en) 2019-11-07 2026-04-21 Icahn School Of Medicine At Mount Sinai Synthetic modified RNA and uses thereof
EP4058584A4 (en) * 2019-11-11 2023-12-20 Icahn School of Medicine at Mount Sinai GENE DELIVERY SYSTEMS FOR THE TREATMENT OF HEART FAILURE
WO2022261206A1 (en) 2021-06-09 2022-12-15 Icahn School Of Medicine At Mount Sinai Gene combination as a broad spectrum antiviral
EP4355882A2 (en) * 2021-06-15 2024-04-24 Modernatx, Inc. Engineered polynucleotides for cell-type or microenvironment-specific expression
CN114085834A (zh) * 2021-11-16 2022-02-25 珠海中科先进技术研究院有限公司 一种癌细胞导向电路组及应用
EP4514965A1 (en) * 2022-04-27 2025-03-05 The Penn State Research Foundation Modrna-based cas endonuclease and base editor and uses thereof
US20230364267A1 (en) * 2022-05-13 2023-11-16 The Uab Research Foundation Pre-clinical modified rna approaches used in large animals for muscle and vascular regeneration
EP4282963A1 (en) * 2022-05-23 2023-11-29 Eberhard Karls Universität Tübingen, Medizinische Fakultät Nucleic acid modified biological cell with expansion-dependent gene expression
WO2024015729A1 (en) * 2022-07-11 2024-01-18 Icahn School Of Medicine At Mount Sinai Regulatory system for expression of a gene of interest in a target cell and method of use thereof
WO2024026254A1 (en) * 2022-07-26 2024-02-01 Modernatx, Inc. Engineered polynucleotides for temporal control of expression
CN116785501A (zh) * 2022-08-04 2023-09-22 上海交通大学医学院附属上海儿童医学中心 促进心脏组织修复的modRNA转染改造的细胞及其应用
WO2024151975A1 (en) 2023-01-13 2024-07-18 Igor Lednev Detecting degradation of a polynucleotide by raman spectroscopy
CN119120571B (zh) * 2024-09-11 2026-03-17 武汉科技大学 一种治疗hiv感染的靶向外泌体嵌合抗原受体分子的构建及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333886T2 (de) 1992-11-18 2006-07-27 Arch Development Corp., Chicago Adenovirus-gelenkter Gen-Transfer zum Herz-und glattem vaskulären Muskel
US20090005336A1 (en) * 2007-05-08 2009-01-01 Zhiguo Wang Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions
US8808982B2 (en) * 2009-12-07 2014-08-19 Cellscript, Llc Compositions and methods for reprogramming eukaryotic cells
WO2012012739A2 (en) * 2010-07-22 2012-01-26 President And Fellows Of Harvard College Multiple input biologic classifier circuits for cells
EP3460064B8 (en) 2011-04-03 2024-03-20 The General Hospital Corporation d/b/a Massachusetts General Hospital Efficient protein expression in vivo using modified rna (mod-rna)
EP2584040A1 (en) * 2011-10-17 2013-04-24 Pharmahungary 2000 Kft. Compounds for treatment of ischemic injury
WO2013188787A1 (en) * 2012-06-15 2013-12-19 The General Hospital Corporation INHIBITORS OF MICRORNAs THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF
WO2014093574A1 (en) * 2012-12-13 2014-06-19 Moderna Therapeutics, Inc. Modified polynucleotides for altering cell phenotype
US10538740B2 (en) 2014-03-20 2020-01-21 Kyoto University Method for sorting cardiomyocytes
US11351271B2 (en) * 2014-09-08 2022-06-07 Massachusetts Institute Of Technology RNA-based logic circuits with RNA binding proteins, aptamers and small molecules
CA3036710A1 (en) * 2016-09-16 2018-03-22 Icahn School Of Medicine At Mount Sinai Cell-specific expression of modrna

Similar Documents

Publication Publication Date Title
JP2023123520A5 (https=)
JP2024528469A (ja) 組換え環状rnaからの改良されたタンパク質翻訳のための組成物及び方法
Wittek et al. Mapping of a gene coding for a major late structural polypeptide on the vaccinia virus genome
JP2022091989A5 (https=)
Astell et al. Structure and replication of minute virus of mice DNA
CN111206053B (zh) 基于CRISPR-Cas13的RNA编辑系统及应用
JP2017079759A5 (https=)
JP2012509678A5 (https=)
JPH04507198A (ja) 核酸の交雑、増幅方法
FI3597749T3 (fi) Menetelmiä ja koostumuksia rna-ohjattua kohde-dna-modifikaatiota varten ja rna-ohjattua transkription modulaatiota varten
BR0016145A (pt) Clones infecciosos
JP2022545950A5 (https=)
JP2023527766A5 (https=)
JP2021522858A5 (https=)
JP2021513866A5 (https=)
RU2022103641A (ru) Искусственная модификация генома для регуляции экспрессии гена
BRPI0006915B8 (pt) processo para preparação de l-aminoácidos
WO2023242425A1 (en) Compositions and methods for circular rna affinity purification
ES2708750T3 (es) Secuencias de miARN de TTV como marcador temprano para el desarrollo futuro de cáncer y como diana para el tratamiento y la prevención del cáncer
JP2023503797A5 (https=)
JP2021522825A5 (https=)
Billeter et al. Nucleotide Sequence Analysis of an Enzymatically Synthesized RNA Corresponding to the 5′-Terminal Region of Qβ RNA
Moccia et al. Structural insights on tiny peptide nucleic acid (PNA) analogues of miRNA-34a: An in silico and experimental integrated approach
CN115397475B (zh) 牛痘病毒聚合酶介导的病毒复制
CN108018267A (zh) 一种靶向表观基因调控抗乙型肝炎病毒分子HBx1C及其应用